Related by context. All words. (Click for frequent words.) 74 oncolytic virus therapies 73 platforms GVAX 73 Nanobody 73 vaccines oncolytic virus 72 product platforms GVAX 72 Myocet 71 XmAb 71 HSP# inhibitor 71 Angiocept 71 oral prodrug 71 MEK inhibitors 70 DXL# 70 Factor VIIa 70 immunotherapeutics 70 BCR ABL inhibitors 70 IMA# 70 proteasome inhibitor 70 GAP #B# 70 Zolinza 70 DOS# 70 PDE4 inhibitor 69 IAP inhibitors 69 Archexin 69 isoform selective 69 Onconase 69 therapeutic monoclonal antibody 69 CBLC# 69 cancer immunotherapy 69 Nanobody ® 69 OncoVEX 69 Panzem R NCD 69 targeted radiotherapeutic 69 therapeutic monoclonal antibodies 69 HuLuc# 69 Pertuzumab 69 Mepact 69 VitiGam 69 TBC# 69 Panzem 69 GRNVAC1 69 selective immunoproteasome inhibitor 69 TELINTRA 69 nanoviricides 69 Celator 68 Personalized Immunotherapy 68 PEG SN# 68 proteasome inhibitors 68 Tarmogen 68 immunotherapeutic 68 AEG# 68 Azedra 68 Cardio Vascu Grow 68 Adnectin 68 novel peptide 68 lapatinib Tykerb 68 CD# monoclonal antibody 68 preclinically 68 Mipomersen 68 Civacir 68 epothilones 68 THR beta agonist 68 epothilone 68 TRAIL receptor antibodies 68 CD# antibody [001] 68 humanized anti 68 Curaxin CBLC# 68 multitargeted 68 siRNA therapeutics 68 tranilast 68 HyACT 68 BRAF inhibitor 68 Cintredekin Besudotox 68 Xcytrin R 68 ENMD # 68 reslizumab 68 FOLOTYN ® 68 mertansine 67 HCV protease inhibitors 67 OMP #M# 67 BiTE 67 prophylactic vaccine 67 RECOTHROM R 67 Allovectin 7 R 67 DPX Survivac 67 antiangiogenesis therapies 67 Solazed TM 67 NTDDS 67 entinostat 67 motexafin gadolinium Injection 67 targeting CD# 67 YONDELIS 67 therapeutic peptide 67 oral taxane 67 tyrosine kinase inhibitor 67 novel antibody therapeutics 67 ocular formulation 67 Bioral ® 67 oncolytic 67 molecularly targeted 67 Epratuzumab 67 anticancer compounds 67 MVA BN R 67 JAK inhibitor 67 MKC# MT 67 Amplimexon 67 EGEN 67 Urocidin 67 humanized antibodies 67 Exherin TM 67 MyVax R 67 Fodosine 67 ALN PCS 67 Sym# 67 anticancer therapeutics 67 HGS# 67 humanized antibody 67 preclinical compounds 67 tiapamil 67 IL# PE#QQR 67 trastuzumab DM1 T DM1 67 SARMs 67 Curaxin 67 Gleevec imatinib mesylate 67 midstage studies 67 Symadex 67 cilengitide 67 adrenergic regulation 67 VALSTAR 67 MAbs 67 Alocrest 67 humanized monoclonal antibodies 67 immunotherapeutic vaccine 67 vascular disrupting agents 67 Tarvacin TM 67 OHR/AVR# 67 biologic therapeutics 67 Nexavar ® 67 CD# CEA 67 tubulin inhibitor 66 SERMs 66 product Fentanyl TAIFUN 66 Aganocide ® 66 TRV# [001] 66 HGS ETR1 66 XmAb# 66 histone deacetylase HDAC 66 personalized immunotherapy 66 JAK1 66 ONCONASE R 66 proprietary LNA 66 antisense drugs 66 GVAX ® 66 mAbs 66 BioVant 66 Intarcia 66 Onalta ™ 66 Zemiva TM 66 obatoclax 66 TLR9 agonist 66 Chimigen 66 theranostic 66 PORxin TM 66 ZK EPO 66 Proxinium TM 66 investigational monoclonal antibody 66 JAK inhibitors 66 rxRNA 66 Campath ® 66 polymerase inhibitors 66 PXD# 66 Allovectin 7 66 OncoVex 66 systemic RNAi 66 PSMA ADC 66 investigational humanized monoclonal antibody 66 Xanafide 66 dasatinib Sprycel 66 Chimigen TM 66 TG# [003] 66 Vaccinex 66 HyperAcute 66 Litx 66 monoclonal antibody therapeutics 66 Tesetaxel 66 otelixizumab 66 alvespimycin 66 deforolimus 66 LEUKINE 66 Octreotide 66 Carfilzomib 66 thymalfasin 66 Insegia 66 hypoxia activated prodrug 66 Maxy G# 66 Phase #b/#a clinical 66 Aflibercept 66 L BLP# 66 MAXY VII 66 URG# 66 SinuNase TM 66 eniluracil 66 ZEVALIN ® 66 Charlesson 66 EndoTAG TM 66 volociximab 66 CYC# 66 tafamidis 66 Bioral 66 siRNA therapeutic 66 Onalta 66 prostone 66 Fc fusion protein 65 Ceflatonin 65 MyVax 65 antisense drug 65 Trofex TM 65 CCR9 antagonist 65 patented Bioral 65 novel therapeutic antibodies 65 OncoVEX GM CSF 65 selective androgen receptor modulators 65 Fleximer 65 elotuzumab 65 Panzem R 65 Chemokine Therapeutics 65 Theratope 65 renin inhibitors 65 mapatumumab 65 NEUGENE 65 Zybrestat 65 Lpathomab 65 Surfaxin LS 65 BAY #-# 65 Fludara ® 65 investigational pan BCR 65 Urokinase 65 Aplidin 65 oncology therapeutics 65 TOCOSOL Camptothecin 65 Guanilib 65 bispecific antibody 65 exon skipping 65 oncolytic virus 65 MOZOBIL 65 oral proteasome inhibitor 65 Fleximer R 65 investigational therapies 65 pan HDAC inhibitor 65 EGFR HER 65 cathepsin K inhibitor 65 HuMax CD4 65 OXi# 65 BiovaxID TM 65 drug conjugate 65 Onco TCS 65 MAXY G# 65 SAR# [002] 65 pertuzumab 65 plasmid DNA vaccine 65 bafetinib 65 ixabepilone 65 anticancer therapies 65 epigenetic therapies 65 Micromet BiTE 65 OvaRex R 65 HQK 65 TLR agonists 65 Squalamine 65 AQ4N 65 CEQ# 65 JAK3 65 bevacizumab Avastin ® 65 PEGylated interferon 65 receptor tyrosine kinase inhibitor 65 liposomal formulation 65 Phase IIb clinical trials 65 anti CD3 65 radiation sensitizer 65 monoclonal antibody MAb 65 immatics 65 GALNS 65 BHT DNA 65 erlotinib Tarceva R 65 PI3K/Akt pathway inhibitor 65 MKC# MKC# PP 65 nicotinic alpha 7 65 ALN VSP 65 Sphingomab TM 65 Pimavanserin 65 Locked Nucleic Acid LNA 65 telomerase therapeutic 65 MCSP respectively 65 Homspera TM 65 Marqibo TM 65 CYT# potent vascular disrupting 65 Locked Nucleic Acid 65 Ridaforolimus 65 NP2 Enkephalin 65 adipiplon 65 INT# [002] 65 Dapagliflozin 65 ATL/TV# 65 CORT # 65 OvaRex ® MAb 65 Leukine 65 PEGylated 65 HuMax TAC 65 erlotinib Tarceva ® 65 protein kinase inhibitor 65 huC# DM4 65 novel peptides 65 Affinitak 65 angiogenesis inhibitor 65 PARP inhibitors 65 Xcellerated T Cells 65 Tyrima 65 Hsp# inhibition 65 BrachySil TM 65 ASONEP 65 Targeted Chemotherapy 65 Azedra TM 65 gefitinib Iressa 65 HepeX B 65 trastuzumab Herceptin 65 BRAF inhibitors 65 zanolimumab 65 novel anti infective 65 using Crucell PER.C6 65 YONDELIS R 65 CCX# 65 Pervasis 65 DNAi 65 sodium thiosulfate STS 64 Ambrx 64 molecular imaging radiopharmaceutical 64 RGB # 64 ospemifene 64 belinostat 64 Quinamed 64 Targretin 64 VEGF inhibitors 64 Trastuzumab 64 POTELLIGENT ® 64 rhThrombin 64 Annamycin 64 JAK2 inhibitors 64 ApoB SNALP 64 Nautilus Biotech 64 MT#/MEDI-# 64 histone deacetylase inhibitor 64 MAb 64 Trofex 64 anti CD3 monoclonal 64 Mpex 64 MGd 64 rifalazil 64 oral antiviral 64 thalidomide Thalomid 64 ProNAi 64 Ramoplanin 64 metaglidasen 64 Telintra 64 anti CD# antibodies 64 MEK inhibitor RDEA# 64 immunotherapeutic agent 64 XL# XL# 64 SCIB1 64 PI3K inhibitors 64 Ketotransdel 64 EndoTAG TM -1 64 IAP inhibitor 64 Sphingomab 64 LEX System 64 Receptos 64 IRX 2 64 Tarvacin 64 lumiliximab 64 unique PER.C6 64 imatinib Gleevec 64 Romidepsin 64 MAGE A3 ASCI 64 Vaxfectin TM 64 BiovaxID 64 ionotropic glutamate receptor antagonists 64 FoldRx 64 RNAi therapeutic targeting 64 REOLYSIN ® 64 Bezielle 64 investigational compounds 64 IMiD 64 novel immunotherapeutic 64 SNALP 64 CINTREDEKIN BESUDOTOX 64 romazarit 64 acetonide FA 64 rituximab Rituxan 64 trastuzumab Herceptin R 64 Gemin X 64 Abiraterone acetate 64 GTC recombinant human 64 docetaxel Taxotere ® 64 novel antiviral therapeutics 64 rNAPc2 64 Aganocide 64 Leukine ® 64 phase IIb clinical 64 CD3 monoclonal antibody 64 selective androgen receptor modulator 64 #I TM# 64 Daclizumab 64 next generation URAT1 64 MEK inhibitor 64 NXL# 64 acyclovir Lauriad R 64 nilotinib Tasigna 64 Taligen 64 NEUGENE R 64 highly selective endothelin 64 AzaSite Plus 64 AVI NEUGENE 64 DXL TM 64 SIR Spheres 64 delta isoform 64 HepeX B TM 64 ALK inhibitors 64 humanized monoclonal antibody 64 theranostics 64 anticancer agents 64 ProSavin 64 Scancell 64 SNALP technology 64 IV Busulfex 64 antiviral compounds 64 docetaxel Taxotere R 64 phase IIa clinical 64 midstage trials 64 kinase inhibitors 64 DAVANAT 64 Vandetanib 64 kidney urologic 64 NPC 1C 64 anticoagulant reversing agent 64 tanespimycin 64 NexACT 64 Hybridon 64 PNP inhibitor 64 Pradefovir 64 cannabinor 64 PLK1 SNALP 64 protein kinase inhibitors 64 DepoVax TM 64 anti angiogenic agents 64 NNR Therapeutics 64 Novosom 64 Amrubicin 64 anticancer compound 64 Fentanyl Taifun 64 therapeutic antibody 64 ONCONASE 64 Selective Electrochemical Tumor Ablation 64 Spiegelmer ® 64 predictive biomarkers 64 DCVax R 64 TKM PLK1 64 TYZEKA 64 polysaccharide polymer 64 anticancer agent 64 Lixivaptan 64 oncolytic viruses 64 drug GAP #B# 64 Bioral Amphotericin B. 64 Ceplene TM 64 vemurafenib 64 Phase Ib clinical trials 64 Alferon N 64 intranasal insulin product 64 cMET 64 Vidofludimus 63 intranasal formulation 63 clinically validated targets 63 Intravenous CP 63 ProLindac 63 Capesaris 63 BrachySil 63 GRN#L 63 vascular disrupting agent 63 fenretinide 63 MVA BN 63 Cellerant 63 CDK inhibitors 63 PI3K inhibitor 63 anti infective treatments 63 cellular immunotherapy 63 Anticalin 63 liposomal 63 faropenem 63 treat male hypogonadism 63 Liposomal 63 PKC# 63 Intravenous Human 63 Etubics 63 orally dosed 63 EP #R 63 Avila Therapeutics 63 anti angiogenic drugs 63 Solazed ™ 63 Icatibant 63 RNA antagonist 63 PARP inhibitor 63 NS#/#A protease 63 EOquin 63 novel immunotherapies 63 Synavive 63 Nanobodies 63 biosurgical 63 Nanobodies ® 63 TKM ApoB 63 multi kinase inhibitor 63 PANVAC VF 63 CA4P 63 inhibit EGFR 63 XmAb ® 63 Irinotecan 63 Cylene 63 Unit Dose Budesonide 63 RECOTHROM ® 63 ATL# [001] 63 Ozarelix 63 #D#C# 63 teplizumab 63 Marqibo 63 Exelixis compounds 63 Trastuzumab DM1 63 StaphVAX 63 selective kinase inhibitor 63 GeneICE 63 HepDirect 63 LNP formulations 63 hematological cancers 63 tyrosine kinase inhibitors 63 EyeGate 63 targeted antifolate 63 Troxatyl 63 MT# MEDI 63 Aviptadil 63 PSN# [002] 63 histone deacetylase HDAC inhibitor 63 pradefovir 63 including eniluracil ADH 63 AMPK activators 63 Onalta TM 63 ESBA# 63 CoFactor 63 Interferon alpha 63 proprietary PEGylation 63 tremelimumab 63 OMAPRO 63 NeuVax 63 Virulizin ® 63 antisense inhibitors 63 novel immunomodulatory 63 cetuximab Erbitux R 63 Elagolix 63 HepDirect R 63 Pancreate 63 AAG geldanamycin analog 63 ruxolitinib 63 TOCOSOL 63 neratinib 63 Cetrorelix 63 etanercept Enbrel 63 HuMax CD# 63 Anticalin R 63 PEP# [003] 63 Telatinib 63 Viramidine 63 milatuzumab 63 nalbuphine ER 63 peptidomimetic 63 GRN# 63 Radezolid 63 Gefitinib 63 allosteric modulator 63 TOCOSOL Paclitaxel 63 enzastaurin 63 antibody MAb 63 stem cell therapeutics 63 REG1 63 ARIKACE ™ 63 atacicept 63 Alnylam RNAi 63 CRD5 63 BZL# 63 FluCide 63 AzaSite Xtra 63 Sorafenib Nexavar 63 ZFP Therapeutics 63 amrubicin 63 UltiMAb 63 UPLYSO 63 IMC #B 63 cetuximab Erbitux ® 63 oncolytic virus therapy 63 SuperAntibody 63 RhuDex ® 63 sorafenib Nexavar 63 ISF# 63 trastuzumab DM1 63 EGFR inhibitors 63 PRT# 63 CR# vcMMAE 63 vinca alkaloid 63 cancer vaccine Norelin 63 cediranib 63 Nexavar sorafenib 63 Allovectin 7 r 63 novel anticancer 63 glucokinase activator 63 Cobalamin 63 seliciclib CYC# 63 nanoviricide 63 triphendiol 63 tolevamer 63 recombinant factor VIIa 63 Sutent sunitinib 63 Traficet EN 63 OncoGel 63 AKT inhibitor 63 nucleoside analogues 63 ganetespib 63 Iluvien ® 63 vorinostat 63 muscarinic receptor agonist 63 telomerase inhibitor 63 Novavax VLP vaccine 63 vivo validation 63 Ceflatonin R 63 Angiolix 63 Erbitux cetuximab 63 Viprovex TM 63 Homspera 63 Silodosin 63 therapeutic regimens 63 candidate AQ4N 63 stable nucleic acid 63 generation proteasome inhibitor 63 AVP #D# 63 Deforolimus 63 Aerosurf 63 Smac mimetic 63 MGCD# [001] 63 RNA antagonists 63 rolapitant 63 bevacizumab Avastin 63 MYDICAR ® 63 DepoVax 63 Atiprimod 63 talactoferrin 63 depsipeptide 63 PDX pralatrexate 63 ATIR 63 CobaCyte 63 immunotoxin 63 LHRH antagonists 63 Revlimid lenalidomide 63 telaprevir VX 63 monoclonal antibody mAb 63 immunological diseases 63 Thiarabine 63 antibody therapeutics 63 delafloxacin 63 visilizumab 63 small molecule inhibitors 63 KNS # 63 Sopherion 63 Loramyc R 63 ASONEP TM 62 potent anticancer 62 S1P antibody 62 hormone gastrin 62 small molecule defensin 62 Neulasta ® 62 cangrelor 62 NovaBay Aganocide compounds 62 Dyax phage display 62 Hsp# inhibitor 62 biobetter 62 HCV antiviral 62 indibulin 62 IMC A# 62 NV1FGF 62 Reports Preclinical Data 62 XmAb ™ 62 DCVax 62 Anidulafungin 62 vosaroxin 62 A3 adenosine receptor 62 Immunotherapeutic 62 Davanat 62 Phase Ib II 62 Thiovir 62 small molecule PEGylation 62 Spiegelmer 62 SinuNase ™ 62 vidofludimus 62 novel RNAi therapeutics 62 erlotinib Tarceva 62 anti infective ophthalmic 62 Anaphore 62 Endotis 62 Neotropix 62 Bendavia 62 TLK# 62 IgG1 monoclonal antibody 62 SinuNase 62 protein therapeutics 62 Aquinox 62 FavId 62 histamine dihydrochloride 62 HDL Mimetic Peptide 62 plasmid DNA pDNA 62 HCD# [002] 62 anti CD# antibody 62 Cleviprex TM clevidipine 62 GVAX 62 AVE# 62 Vectibix panitumumab 62 BEMA TM Fentanyl 62 exemestane Aromasin 62 OMP #R# 62 Revimmune 62 lintuzumab 62 synthetic retinoid 62 histone deacetylase HDAC inhibitors 62 Lucanix R 62 lucinactant 62 BiTE antibody 62 Kosan dependence 62 Tranzyme 62 Resten NG 62 MyVax ® 62 DNA plasmids 62 JVRS 62 Aurexis 62 recombinant antibodies 62 TACI Ig 62 PEGylation technology 62 corticosteroid dexamethasone 62 Accentia Biopharmaceuticals 62 Smac mimetics 62 Pralatrexate 62 Stapled Peptide 62 cHTS 62 transcutaneous immunization TCI 62 INCB# [001] 62 paclitaxel Taxol 62 subcutaneous formulation 62 Diamyd ® 62 compound AEZS 62 StemEx 62 EGS# 62 Vidaza R 62 Apoptone 62 Liprostin 62 TapImmune 62 Catena ® 62 ACTCellerate 62 Neuradiab 62 forodesine 62 FUSILEV ® 62 OvaRex 62 inhibit metastasis 62 NP2 62 Hedgehog antagonist 62 adenovector 62 PROfusion 62 ponatinib 62 virus HCV protease inhibitor 62 Dalbavancin 62 RNAi therapeutic 62 efaproxiral 62 Novolimus 62 endothelin antagonist 62 relapsed leukemia 62 JAK2 inhibitor 62 angiogenesis inhibition 62 orally bioavailable 62 AtuRNAi 62 Spiegelmers ® 62 immunotherapies 62 bardoxolone 62 mucosal vaccines 62 Plasmin 62 HepaLife 62 Zalypsis 62 delivery polymer matrix 62 regorafenib 62 HCV protease inhibitor 62 signal transduction inhibitor 62 MOVIPREP R 62 FGFR 62 afamelanotide 62 ulimorelin 62 incyclinide 62 candidates Azedra 62 antisense oligonucleotide 62 RIGScan CR 62 StaphVax 62 isavuconazole 62 DiLA2 62 cetuximab Erbitux 62 Dasatinib 62 StemEx R 62 Seliciclib 62 TELCYTA 62 Nuvion 62 GPCR targets 62 chemical entities NCEs 62 PrevOnco 62 DiaKine 62 Evoltra ® 62 Potelligent Technology 62 dacetuzumab 62 PNT# 62 therapeutic mAbs 62 candidate TNFerade biologic 62 HGS ETR2 62 gastro intestinal inflammation 62 DCVax ® 62 nanomedicines 62 antisense 62 Chemophase 62 Initiate Clinical Trial 62 CD# antibodies 62 anti idiotype 62 antiviral therapeutics 62 LEP ETU 62 PolyActive ® 62 Epitomics 62 torezolid 62 DAVANAT R 62 methylnaltrexone 62 radezolid 62 pralatrexate 62 biologic therapies 62 Ophthotech 62 Ixempra 62 Regado 62 chemotherapeutics 62 NEUMUNE 62 novel L DOS# 62 gastrin 62 PrevOnco ™ 62 IgG1 antibody 62 beta 1a 62 Acuity Pharmaceuticals 62 Veronate 62 GlycoPEGylation TM technologies 62 SAR# [004] 62 imatinib Gleevec ® 62 recombinant albumin 62 targets Galectin receptors 62 Gleevec resistant 62 OTCBB CVBT 62 accumulate preferentially 62 Shigamabs ® 62 pomalidomide 62 monoclonal antibody therapies 62 aerosolized AAT 62 MabThera rituximab 62 OraTest 62 Vaxfectin 62 Memryte 62 Factor Xa inhibitor 62 HuMax 62 ghrelin antagonist 62 Aegera 62 2 methoxyestradiol 62 Kevetrin 62 custirsen 62 candidate CRLX# 62 Blinatumomab 62 ROTARIX 62 Zingo TM 62 favorable pharmacokinetic profile 62 GW# [003] 62 Harbor BioSciences 62 Granulocyte Colony Stimulating Factor 62 Temsirolimus 62 HCV polymerase inhibitors 62 polyclonal antibody 62 immunotherapy 62 LY# [003] 62 liposomal doxorubicin 62 myelofibrosis polycythemia vera 62 Anticalin ® 62 GeoVax vaccine 62 humanized monoclonal 62 Cethromycin 62 HuMax EGFr 62 Genentech Roche 62 ProMune 62 Neovastat 62 HDACi 62 molecular imaging radiopharmaceuticals 62 Avicena 62 voclosporin 62 Manja Bouman CEO 62 tezampanel 62 ChronVac C R 62 Alfacell proprietary ribonuclease 62 apricitabine ATC 62 anidulafungin 62 personalized cellular immunotherapy 62 ELACYT 62 Imprime PGG 62 humanised monoclonal antibody 62 Mycograb 62 maribavir 62 Restanza 62 Neugene 62 FVIIa 62 VQD 62 Velcade bortezomib 62 Isis antisense 62 ALN TTR# 62 Neo Kidney Augment 62 rALLy clinical trial 62 sorafenib tablets 62 Pazopanib 62 iSONEP 62 immunotherapeutic approaches 62 Aptocine 62 Aurora kinase inhibitor 62 FluoroPharma 62 Tumour Vascular Disrupting Agent 61 Neuvenge 61 Degarelix 61 ATL# [002] 61 defensin mimetic antibiotic 61 Ostarine 61 therapeutics 61 nitric oxide donating 61 Bortezomib 61 Cethrin R 61 HTS assay 61 HuMax HepC TM 61 Preclinical studies suggest 61 mitogen activated ERK kinase 61 octreotide implant 61 antisense oligonucleotides 61 Injectable Suspension 61 VentiRx 61 HspE7 61 Lisofylline LSF 61 SEBIVO 61 ERYtech Pharma 61 BNC# 61 Versartis 61 Nektar pulmonary 61 Reolysin 61 RAF kinase 61 vaccine GRNVAC1 61 PREVENAR 61 OXIGON 61 Adenosine Therapeutics 61 anastrozole Arimidex 61 selective orally bioavailable 61 Augment TM 61 product platforms AZX# 61 ARRY # 61 HDAC inhibitors 61 Pentad TM 61 mTOR inhibition 61 mda 7 61 motesanib 61 dermatology therapies 61 immune modulating 61 INS# [001] 61 adenoviral 61 recombinant biopharmaceutical 61 RenaZorb TM 61 farletuzumab 61 IMPACS R 61 ATG Fresenius S 61 selective modulator 61 Abiraterone 61 Cloretazine ® 61 FOLFOX chemotherapy 61 miRview mets 61 Glypromate 61 Prestara TM 61 HepaGam B 61 Protexia R 61 Cyclosert 61 RNA interference RNAi therapeutics 61 virosome 61 immunotoxins 61 immunomodulatory